220 related articles for article (PubMed ID: 12971798)
1. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.
Markushin Y; Zhong W; Cavalieri EL; Rogan EG; Small GJ; Yeung ES; Jankowiak R
Chem Res Toxicol; 2003 Sep; 16(9):1107-17. PubMed ID: 12971798
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic characterization of the 4-hydroxy catechol estrogen quinones-derived GSH and N-acetylated Cys conjugates.
Jankowiak R; Markushin Y; Cavalieri EL; Small GJ
Chem Res Toxicol; 2003 Mar; 16(3):304-11. PubMed ID: 12641430
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
[TBL] [Abstract][Full Text] [Related]
4. Potential biomarker for early risk assessment of prostate cancer.
Markushin Y; Gaikwad N; Zhang H; Kapke P; Rogan EG; Cavalieri EL; Trock BJ; Pavlovich C; Jankowiak R
Prostate; 2006 Oct; 66(14):1565-71. PubMed ID: 16894534
[TBL] [Abstract][Full Text] [Related]
5. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
Cavalieri E; Rogan E
Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
[TBL] [Abstract][Full Text] [Related]
6. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
7. Spectral characterization of fluorescently labeled catechol estrogen 3,4-quinone-derived N7 guanine adducts and their identification in rat mammary gland tissue.
Jankowiak R; Zamzow D; Stack DE; Todorovic R; Cavalieri EL; Small GJ
Chem Res Toxicol; 1998 Nov; 11(11):1339-45. PubMed ID: 9815195
[TBL] [Abstract][Full Text] [Related]
8. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
Saeed M; Gunselman SJ; Higginbotham S; Rogan E; Cavalieri E
Steroids; 2005 Jan; 70(1):37-45. PubMed ID: 15610895
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
[TBL] [Abstract][Full Text] [Related]
10. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.
Lu F; Zahid M; Saeed M; Cavalieri EL; Rogan EG
J Steroid Biochem Mol Biol; 2007; 105(1-5):150-8. PubMed ID: 17582757
[TBL] [Abstract][Full Text] [Related]
11. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer.
Devanesan P; Todorovic R; Zhao J; Gross ML; Rogan EG; Cavalieri EL
Carcinogenesis; 2001 Mar; 22(3):489-97. PubMed ID: 11238191
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
[TBL] [Abstract][Full Text] [Related]
13. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
[TBL] [Abstract][Full Text] [Related]
14. Mutagenic properties of estrogen quinone-derived DNA adducts in simian kidney cells.
Terashima I; Suzuki N; Shibutani S
Biochemistry; 2001 Jan; 40(1):166-72. PubMed ID: 11141067
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones.
Stack DE; Li G; Hill A; Hoffman N
Chem Res Toxicol; 2008 Jul; 21(7):1415-25. PubMed ID: 18547067
[TBL] [Abstract][Full Text] [Related]
16. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
Cavalieri EL; Rogan EG
IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
[TBL] [Abstract][Full Text] [Related]
17. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
Cavalieri E; Rogan E
Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
[TBL] [Abstract][Full Text] [Related]
18. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol.
Saeed M; Rogan E; Fernandez SV; Sheriff F; Russo J; Cavalieri E
Int J Cancer; 2007 Apr; 120(8):1821-4. PubMed ID: 17230531
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of depurinating estrogen-DNA adduct formation by natural compounds.
Zahid M; Gaikwad NW; Rogan EG; Cavalieri EL
Chem Res Toxicol; 2007 Dec; 20(12):1947-53. PubMed ID: 18039013
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells.
Zahid M; Saeed M; Beseler C; Rogan EG; Cavalieri EL
Free Radic Biol Med; 2011 Jan; 50(1):78-85. PubMed ID: 20934508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
